Massive Bio has made its inaugural strategic investment in Rivvi. Read the announcement

2027 Star Ratings

H7379

CareFirst BlueCross BlueShield Medicare Advantage

47,293 members

2.5

-1.5 vs 2026Below the 4 star line

Ask about H7379

3 free questions today

Medication adherence

Medication Adherence for Diabetes Medications

3 · 2.0 pt to 4★

Medication Adherence for Hypertension (RAS antagonists)

4 · 3.0 pt to 5★

Medication Adherence for Cholesterol (Statins)

3 · 2.0 pt to 4★

All measures

MeasureStarsScore
C27 Complaints about the Health Plan30.4
C28 Members Choosing to Leave the Plan54%
C17 Plan All-Cause Readmissions3x213%
C10 Osteoporosis Management in Women who had a Fracture116%
C06 Monitoring Physical Activity353%
C15 Reducing the Risk of Falling255%
C16 Improving Bladder Control555%
C20 Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions262%
C11 Diabetes Care – Eye Exam265%
C13 Kidney Health Evaluation for Patients with Diabetes365%

Other plans from this organization

Source: CMS 2027 Part C and D Star Ratings data, released October 8, 2026. Data loaded October 9, 2026.

Try it on your own data today.

Free to start. Most teams are using it the same day.